KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Twist Bioscience (TWST) Restructuring Costs (2019 - 2026)

Twist Bioscience has reported Restructuring Costs over the past 2 years, most recently at $7.2 million for Q1 2026.

  • Quarterly Restructuring Costs changed N/A to $7.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Mar 2026, changed N/A year-over-year, with the annual reading at $22.5 million for FY2020, N/A changed from the prior year.
  • Restructuring Costs was $7.2 million for Q1 2026 at Twist Bioscience, down from $22.5 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $7.2 million in Q1 2026 and troughed at $7.2 million in Q1 2026.